Skip to main content

Breast.

63 studies recruiting right now, most recently updated first.

Open the Phase 2 page · a list of only those studies

Triangle is made by Triangle Health, Inc.

Breast63 studies

Metastatic Breast Cancer in the LiverФаза 2NCT06875128

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

Melphalan/HDS followed by Physician's choice of SOC (eribulin, vinorelbine, or capecitabine), Physician's choice of SOC (eribulin, vinorelbine, or capecitabine)

Delcath Systems Inc.Open the brief

Mesothelin-Expressing TumorsPhase 1NCT06623396Papers

M28z1XXPD1DNR CAR

Mesothelin-Targeted CAR T-Cell Therapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer CenterOpen the brief

HR+/HER2- Breast Cancer Brain MetastasesPhase 1/2NCT04923542

Radiosurgery + Abemaciclib

SR & Abemaciclib With/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

H. Lee Moffitt Cancer Center and Research InstituteOpen the brief

Clinical trials: Phase 1 and Phase 2, explained